PolyPid (PYPD) announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. Story brings over 25 years of leadership experience in the MedTech industry.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PYPD:
- Roth Capital healthcare analyst holds an analyst/industry conference call
- PolyPid Gains FDA Support for D-PLEX100 NDA Submission
- PolyPid receives pre-NDA meeting minutes for D-Plex supporting NDA submission
- PolyPid Expands Share Offering to Strengthen Financial Position
- PolyPid price target lowered to $9 from $10 at Roth Capital